Spyre Therapeutics Stock Up 565% in a Year, But Momentum Now Fades Near Highs
Covered by 1 source · 1 article
Spyre Therapeutics stock remains one of the more explosive biotech stories of the past year. The stock surged roughly 565% over twelve months and touched a fresh three-year high. On Tuesday, SYRE closed at 107.36, down from an intraday high…
Covered by
